Longitude Venture Partners IV, L.P.
SEC CIK 1787456 · EDGAR
BoughtSold
Most active insiders at LXEO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Townsend Richard Nolan | CEO, Dir | — | $655.7K |
| 2 | Bhalla Narinder Pal | Chief Medical Off | — | $98.6K |
| 3 | Otero Jose Manuel | Chief Technical Off | — | $78.9K |
| 4 | Tamayo Louis Edward | CFO | — | $41.0K |
| 5 | See Tai Sandi | Chief Development Off | — | $38.4K |
| 6 | Robertson Jenny | CLO | — | $36.6K |
| 7 | Adler Eric | Chief Medical Off | — | $36.0K |
Longitude Venture Partners IV, L.P. made no open-market trades at LXEO in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-11-09 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Longitude Venture Partners IV, L.P. | 10% | P - Purchase | $11.00 | +454.5K | 2.57M | +22% | +$5.00M |
| DMI | 2023-11-09 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Longitude Venture Partners IV, L.P. | 10% | C - Cnv Deriv | — | +2.11M | 1.79M | New | — |
| I | 2023-02-08 | 2023-02-06 | VERA | Vera Therapeutics, Inc. | Longitude Venture Partners IV, L.P. | 10% | P - Purchase | $7.00 | +1.71M | 1.71M | New | +$12.00M |
Purchase Sale Sale after option exercise All abbreviations